Valuation: Monto Minerals Ltd

Market Cap 35.11M 24.66M 21.64M 20.44M 18.62M 34.86M 2.36B 245M 94.72M 1.21B 92.58M 90.58M 3.88B P/E 2025
-3.77x
P/E 2026 -8.1x
Enterprise Value 31.7M 22.26M 19.54M 18.45M 16.81M 31.48M 2.13B 221M 85.52M 1.09B 83.59M 81.78M 3.5B EV / Sales 2025
21.1x
EV / Sales 2026 1,648x
Free-Float
17.5%
Yield 2025 *
-
Yield 2026 -
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer - 1994-01-16
Chief Executive Officer - 2026-05-10
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman - 2025-10-20
Director/Board Member - 2025-10-20
Chairman - 2025-11-25
Change 5-day change 1-year change 3-year change Capi.($)
+2.12%+7.87%+0.27%+37.62% 44.5B
-1.63%-5.05%-47.92%+126.16% 11.99B
+2.59%-1.45%-6.92%+112.99% 5.38B
+1.05%-3.11%+44.96% - 4.23B
-5.25%-11.61% - - 2.05B
+1.91%+4.44%+10.36%-30.60% 1.51B
+0.08%-1.95%-36.69% - 1.01B
-0.61%-3.19%+12.27%+155.26% 965M
-1.14%-5.77%+28.32%+43.76% 859M
Average -0.10%-3.36%+0.58%+74.20% 8.06B
Weighted average by Cap. +1.16%+0.85%-5.61%+60.37%

Financials

2025 2026
Net sales 322K 226K 198K 187K 171K 320K 21.67M 2.24M 869K 11.07M 849K 831K 35.59M 47.63K 33.45K 29.35K 27.72K 25.26K 47.29K 3.21M 332K 128K 1.64M 126K 123K 5.26M
Net income -1.45M -1.02M -892K -843K -768K -1.44M -97.45M -10.08M -3.91M -49.78M -3.82M -3.73M -160M -3.65M -2.57M -2.25M -2.13M -1.94M -3.63M -246M -25.44M -9.85M -126M -9.63M -9.42M -404M
Net Debt -25.17K -17.67K -15.51K -14.65K -13.35K -24.99K -1.69M -175K -67.89K -865K -66.36K -64.92K -2.78M -3.41M -2.39M -2.1M -1.98M -1.81M -3.39M -230M -23.75M -9.2M -117M -8.99M -8.8M -377M
Logo Monto Minerals Ltd
Pathkey.AI Ltd, formerly Opyl Limited, is an artificial intelligence (AI) company. The Company leverages data and technology to transform the landscape of clinical trials and medical research. It is a digital health company specializing in leveraging artificial intelligence technologies to elevate clinical trial design and forecast outcomes, empowering clinical researchers, biopharmaceutical corporations, and medical investors to enhance trial design, drug development, and market delivery. Its Social Media Insights solution captures and analyses online public conversations from people living with a medical condition, healthcare professionals, carers, and researchers. Its TrialKey platform provides users access to tailored and actionable steps to address critical trial challenges. The Company specializes in applying AI and predictive analytics to social media to accelerate therapy adoption and market development in the healthcare industry.
Employees
-